CPIX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 42.07%

Insider Buying (Last 12 Months): $479.66

Insider Selling (Last 12 Months): $0.00

Cumberland Pharmaceuticals Insider Trading History Chart

Cumberland Pharmaceuticals Share Price & Price History

^$1.70

▲ +0.05 (3.03%)

As of 12/6/2023 12:00 PM ET

Days: 30 | 90 | 365

Trading Experts Call It “The Perfect Tesla Trade”

From Wealthpress | Ad

Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.

Click here for details,

Cumberland Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/21/2022	James Jones	Director	Buy	88	$2.22	$195.36	26,293
12/19/2022	Caroline Young	Director	Buy	30	$2.21	$66.30	19,478
12/16/2022	Caroline Young	Director	Buy	20	$2.22	$44.40	19,448
12/14/2022	Caroline Young	Director	Buy	20	$2.21	$44.20	19,408
12/12/2022	Caroline Young	Director	Buy	20	$2.14	$42.80	19,368
12/9/2022	Caroline Young	Director	Buy	20	$2.15	$43.00	19,348
12/7/2022	Caroline Young	Director	Buy	20	$2.18	$43.60	19,308
12/5/2022	Caroline Young	Director	Buy	20	$2.19	$43.80	19,268
12/1/2022	Caroline Young	Director	Buy	20	$2.33	$46.60	19,228
11/28/2022	Caroline Young	Director	Buy	20	$2.37	$47.40	19,168
11/25/2022	Caroline Young	Director	Buy	20	$2.31	$46.20	19,148
11/23/2022	Caroline Young	Director	Buy	20	$2.29	$45.80	19,128
11/21/2022	Caroline Young	Director	Buy	20	$2.38	$47.60	19,088
11/18/2022	Caroline Young	Director	Buy	20	$2.27	$45.40	19,068
11/16/2022	Caroline Young	Director	Buy	20	$2.31	$46.20	19,028
11/14/2022	Caroline Young	Director	Buy	20	$2.32	$46.40	18,988
11/11/2022	Caroline Young	Director	Buy	20	$2.32	$46.40	18,968
11/9/2022	Caroline Young	Director	Buy	20	$2.37	$47.40	18,928
11/7/2022	Caroline Young	Director	Buy	20	$2.45	$49.00	18,888
11/4/2022	Caroline Young	Director	Buy	20	$2.42	$48.40	18,868
11/2/2022	Caroline Young	Director	Buy	20	$2.54	$50.80	18,828
10/31/2022	Caroline Young	Director	Buy	20	$2.54	$50.80	18,788
10/28/2022	Caroline Young	Director	Buy	20	$2.52	$50.40	18,768
10/26/2022	Caroline Young	Director	Buy	20	$2.42	$48.40	18,728
10/24/2022	Caroline Young	Director	Buy	20	$2.38	$47.60	18,688
10/21/2022	Caroline Young	Director	Buy	20	$2.49	$49.80	18,668
10/19/2022	Caroline Young	Director	Buy	20	$2.42	$48.40	18,628
10/17/2022	Caroline Young	Director	Buy	20	$2.33	$46.60	18,588
10/14/2022	Caroline Young	Director	Buy	20	$2.31	$46.20	18,568
10/12/2022	Caroline Young	Director	Buy	20	$2.49	$49.80	18,528
10/10/2022	Caroline Young	Director	Buy	20	$2.53	$50.60	18,488
10/7/2022	Caroline Young	Director	Buy	20	$2.66	$53.20	18,468
10/5/2022	Caroline Young	Director	Buy	20	$2.58	$51.60	18,428
10/3/2022	Caroline Young	Director	Buy	20	$2.54	$50.80	18,388
9/30/2022	Caroline Young	Director	Buy	20	$2.61	$52.20	18,368
9/28/2022	Caroline Young	Director	Buy	20	$2.52	$50.40	18,328
9/26/2022	Kenneth Krogulski	Director	Buy	105	$2.49	$261.45	197,075
9/23/2022	Kenneth Krogulski	Director	Buy	105	$2.55	$267.75	196,970
9/21/2022	Kenneth Krogulski	Director	Buy	105	$2.59	$271.95	196,760
9/19/2022	Kenneth Krogulski	Director	Buy	105	$2.56	$268.80	196,550
9/16/2022	Kenneth Krogulski	Director	Buy	115	$2.49	$286.35	196,445
9/14/2022	Kenneth Krogulski	Director	Buy	115	$2.51	$288.65	196,215
9/12/2022	Kenneth Krogulski	Director	Buy	115	$2.46	$282.90	195,985
9/8/2022	Kenneth Krogulski	Director	Buy	115	$2.22	$255.30	195,810
9/6/2022	Kenneth Krogulski	Director	Buy	115	$2.15	$247.25	195,580
9/2/2022	Kenneth Krogulski	Director	Buy	115	$2.42	$278.30	195,465
8/31/2022	Kenneth Krogulski	Director	Buy	115	$2.36	$271.40	195,235
8/29/2022	Kenneth Krogulski	Director	Buy	115	$2.44	$280.60	195,005
8/26/2022	Kenneth Krogulski	Director	Buy	110	$2.55	$280.50	194,890
8/24/2022	Kenneth Krogulski	Director	Buy	110	$2.59	$284.90	194,670
8/22/2022	Kenneth Krogulski	Director	Buy	110	$2.51	$276.10	194,450
8/19/2022	Kenneth Krogulski	Director	Buy	110	$2.35	$258.50	194,340
8/17/2022	Kenneth Krogulski	Director	Buy	110	$2.31	$254.10	194,120
8/15/2022	Caroline Young	Director	Buy	20	$2.45	$49.00	17,682
8/12/2022	Caroline Young	Director	Buy	26	$2.52	$65.52	17,662
8/10/2022	Caroline Young	Director	Buy	26	$2.19	$56.94	17,610
8/8/2022	Caroline Young	Director	Buy	26	$2.19	$56.94	17,558
8/5/2022	Caroline Young	Director	Buy	24	$2.12	$50.88	17,532
8/3/2022	Caroline Young	Director	Buy	12	$2.45	$29.40	17,484
8/1/2022	Caroline Young	Director	Buy	24	$2.34	$56.16	17,472
7/29/2022	Caroline Young	Director	Buy	24	$2.28	$54.72	17,448
7/27/2022	Caroline Young	Director	Buy	19	$2.36	$44.84	17,400
7/25/2022	Caroline Young	Director	Buy	24	$2.48	$59.52	17,357
7/22/2022	Caroline Young	Director	Buy	24	$2.53	$60.72	17,333
7/20/2022	Caroline Young	Director	Buy	24	$2.52	$60.48	17,285
7/18/2022	Caroline Young	Director	Buy	24	$2.41	$57.84	17,237
7/14/2022	Caroline Young	Director	Buy	27	$2.28	$61.56	17,186
7/12/2022	Caroline Young	Director	Buy	27	$2.25	$60.75	17,159
7/7/2022	Caroline Young	Director	Buy	27	$2.18	$58.86	17,105
7/5/2022	Caroline Young	Director	Buy	27	$2.18	$58.86	17,051
7/1/2022	Caroline Young	Director	Buy	20	$2.11	$42.20	17,024
6/29/2022	Caroline Young	Director	Buy	28	$2.11	$59.08	16,976
6/27/2022	Caroline Young	Director	Buy	7	$2.06	$14.42	16,925
6/23/2022	Caroline Young	Director	Buy	28	$2.01	$56.28	16,890
6/21/2022	Caroline Young	Director	Buy	28	$1.97	$55.16	16,837
6/17/2022	Caroline Young	Director	Buy	27	$1.94	$52.38	16,809
6/15/2022	Caroline Young	Director	Buy	27	$1.98	$53.46	15,755
6/13/2022	Caroline Young	Director	Buy	27	$2.01	$54.27	16,701
6/10/2022	Caroline Young	Director	Buy	27	$2.04	$55.08	16,674
6/8/2022	Caroline Young	Director	Buy	27	$2.12	$57.24	16,620
6/6/2022	Caroline Young	Director	Buy	27	$2.07	$55.89	16,573
6/2/2022	Caroline Young	Director	Buy	25	$2.08	$52.00	16,521
5/31/2022	Caroline Young	Director	Buy	25	$2.13	$53.25	16,471
5/29/2022	Kenneth Krogulski	Director	Buy	127	$2.13	$270.51	187,617
5/27/2022	Caroline Young	Director	Buy	25	$2.13	$53.25	16,446
5/25/2022	Caroline Young	Director	Buy	25	$2.15	$53.75	16,396
5/23/2022	Caroline Young	Director	Buy	25	$2.17	$54.25	16,346
5/20/2022	Caroline Young	Director	Buy	23	$2.23	$51.29	16,321
5/18/2022	Caroline Young	Director	Buy	23	$2.31	$53.13	16,275
5/16/2022	Caroline Young	Director	Buy	23	$2.31	$53.13	15,229
5/13/2022	Caroline Young	Director	Buy	23	$2.32	$53.36	16,206
5/11/2022	Caroline Young	Director	Buy	23	$2.37	$54.51	16,160
5/9/2022	Caroline Young	Director	Buy	23	$2.63	$60.49	16,114
5/6/2022	Caroline Young	Director	Buy	20	$2.36	$47.20	16,091
5/4/2022	Caroline Young	Director	Buy	20	$2.37	$47.40	16,051
5/2/2022	Caroline Young	Director	Buy	20	$2.45	$49.00	16,011
4/29/2022	Caroline Young	Director	Buy	20	$2.44	$48.80	15,991
4/27/2022	Caroline Young	Director	Buy	20	$2.41	$48.20	15,951
4/25/2022	Caroline Young	Director	Buy	20	$2.62	$52.40	15,911
4/22/2022	Caroline Young	Director	Buy	19	$2.73	$51.87	15,891
4/20/2022	Caroline Young	Director	Buy	19	$2.74	$52.06	15,853
4/18/2022	Caroline Young	Director	Buy	19	$2.63	$49.97	15,815
4/16/2022	Kenneth Krogulski	Director	Buy	94	$2.71	$254.74	184,235
4/14/2022	Caroline Young	Director	Buy	19	$2.71	$51.49	15,796
10/29/2021	Joseph C. Galante	Director	Buy	142	$2.72	$386.24
10/27/2021	Joseph C. Galante	Director	Buy	142	$2.61	$370.62
10/25/2021	Joseph C. Galante	Director	Buy	142	$2.64	$374.88
10/22/2021	Joseph C. Galante	Director	Buy	142	$2.66	$377.72
10/20/2021	Joseph C. Galante	Director	Buy	142	$2.63	$373.46
10/18/2021	Joseph C. Galante	Director	Buy	142	$2.75	$390.50
10/15/2021	Joseph C. Galante	Director	Buy	142	$2.76	$391.92
10/13/2021	Joseph C. Galante	Director	Buy	142	$2.71	$384.82
10/11/2021	Joseph C. Galante	Director	Buy	142	$2.73	$387.66
10/8/2021	Joseph C. Galante	Director	Buy	142	$2.84	$403.28
10/6/2021	Joseph C. Galante	Director	Buy	142	$2.76	$391.92
10/4/2021	A.J. Kazimi	CEO	Buy	15	$2.87	$43.05
10/4/2021	Joseph C. Galante	Director	Buy	142	$2.87	$407.54
10/1/2021	A.J. Kazimi	CEO	Buy	15	$2.69	$40.35
10/1/2021	Joseph C. Galante	Director	Buy	142	$2.69	$381.98
9/29/2021	A.J. Kazimi	CEO	Buy	15	$2.82	$42.30
9/29/2021	Joseph C. Galante	Director	Buy	142	$2.82	$400.44
9/27/2021	A.J. Kazimi	CEO	Buy	15	$2.79	$41.85
9/27/2021	Joseph C. Galante	Director	Buy	142	$2.79	$396.18
9/24/2021	A.J. Kazimi	CEO	Buy	15	$2.74	$41.10
9/24/2021	Joseph C. Galante	Director	Buy	142	$2.74	$389.08
9/22/2021	A.J. Kazimi	CEO	Buy	15	$2.76	$41.40
9/22/2021	Joseph C. Galante	Director	Buy	142	$2.76	$391.92
9/20/2021	A.J. Kazimi	CEO	Buy	15	$2.82	$42.30
9/20/2021	Joseph C. Galante	Director	Buy	142	$2.82	$400.44
9/17/2021	A.J. Kazimi	CEO	Buy	15	$2.85	$42.75
9/17/2021	Joseph C. Galante	Director	Buy	142	$2.85	$404.70
9/15/2021	A.J. Kazimi	CEO	Buy	15	$2.86	$42.90
9/15/2021	Joseph C. Galante	Director	Buy	142	$2.86	$406.12
9/13/2021	A.J. Kazimi	CEO	Buy	15	$2.96	$44.40
9/13/2021	Joseph C. Galante	Director	Buy	142	$2.96	$420.32
9/9/2021	A.J. Kazimi	CEO	Buy	15	$2.77	$41.55
9/9/2021	Joseph C. Galante	Director	Buy	142	$2.77	$393.34
9/7/2021	A.J. Kazimi	CEO	Buy	15	$2.79	$41.85
9/7/2021	Joseph C. Galante	Director	Buy	142	$2.79	$396.18
9/3/2021	A.J. Kazimi	CEO	Buy	15	$2.85	$42.75
9/3/2021	Joseph C. Galante	Director	Buy	142	$2.85	$404.70
9/1/2021	A.J. Kazimi	CEO	Buy	15	$2.88	$43.20
9/1/2021	Joseph C. Galante	Director	Buy	142	$2.88	$408.96
8/30/2021	A.J. Kazimi	CEO	Buy	15	$2.88	$43.20	5,768,844
8/27/2021	A. J. Kazimi	CEO	Buy	15	$2.84	$42.60	5,768,844
8/25/2021	A.J. Kazimi	CEO	Buy	15	$2.79	$41.85
8/23/2021	A.J. Kazimi	CEO	Buy	15	$2.87	$43.05	5,768,844
8/20/2021	A.J. Kazimi	CEO	Buy	15	$2.96	$44.40
8/18/2021	A.J. Kazimi	CEO	Buy	15	$2.97	$44.55
8/16/2021	A.J. Kazimi	CEO	Buy	15	$2.92	$43.80	5,768,844
8/13/2021	A. J. Kazimi	CEO	Buy	15	$2.92	$43.80	5,768,844
8/11/2021	A. J. Kazimi	CEO	Buy	15	$2.98	$44.70	13,058
8/9/2021	A.J. Kazimi	CEO	Buy	15	$2.93	$43.95	5,768,844
8/6/2021	A. J. Kazimi	CEO	Buy	15	$3.01	$45.15	5,768,844
8/4/2021	A.J. Kazimi	CEO	Buy	15	$3.18	$47.70
8/2/2021	A.J. Kazimi	CEO	Buy	15	$3.34	$50.10
7/30/2021	Kenneth Krogulski	Director	Buy	85	$3.31	$281.35	14,742
7/30/2021	Martin E. Cearnal	SVP	Buy	105	$3.31	$347.55	165,054
7/29/2021	A.J. Kazimi	CEO	Buy	15	$3.42	$51.30
7/28/2021	Kenneth Krogulski	Director	Buy	85	$3.42	$290.70
7/28/2021	Martin E. Cearnal	SVP	Buy	105	$3.42	$359.10
7/26/2021	A.J. Kazimi	CEO	Buy	15	$3.41	$51.15
7/26/2021	Kenneth Krogulski	Director	Buy	85	$3.39	$288.15	14,742
7/26/2021	Martin E. Cearnal	SVP	Buy	105	$3.39	$355.95
7/23/2021	A.J. Kazimi	CEO	Buy	15	$3.35	$50.25	5,768,529
7/23/2021	Kenneth Krogulski	Director	Buy	85	$3.35	$284.75	32,559
7/23/2021	Martin E. Cearnal	SVP	Buy	105	$3.35	$351.75
7/21/2021	A. J. Kazimi	CEO	Buy	15	$3.26	$48.90	5,768,529
7/21/2021	Kenneth Krogulski	Director	Buy	85	$3.26	$277.10	32,559
7/21/2021	Martin E. Cearnal	SVP	Buy	105	$3.26	$342.30	165,054
7/19/2021	A. J. Kazimi	CEO	Buy	15	$3.23	$48.45	5,768,529
7/19/2021	Kenneth Krogulski	Director	Buy	85	$3.23	$274.55	14,742
7/19/2021	Martin E. Cearnal	SVP	Buy	105	$3.23	$339.15
7/16/2021	A. J. Kazimi	CEO	Buy	15	$3.28	$49.20	5,768,529
7/16/2021	Kenneth Krogulski	Director	Buy	85	$3.28	$278.80	32,559
7/16/2021	Martin E. Cearnal	SVP	Buy	105	$3.28	$344.40
7/14/2021	A. J. Kazimi	CEO	Buy	15	$3.33	$49.95	5,768,529
7/14/2021	Kenneth Krogulski	Director	Buy	85	$3.33	$283.05
7/14/2021	Martin E. Cearnal	SVP	Buy	105	$3.33	$349.65	165,054
7/12/2021	A.J. Kazimi	CEO	Buy	15	$3.33	$49.95
7/12/2021	Kenneth Krogulski	Director	Buy	85	$3.33	$283.05	32,559
7/12/2021	Martin E. Cearnal	SVP	Buy	105	$3.33	$349.65	165,054
7/8/2021	A. J. Kazimi	CEO	Buy	15	$3.18	$47.70	5,768,529
7/8/2021	Kenneth Krogulski	Director	Buy	85	$3.18	$270.30
7/8/2021	Martin E. Cearnal	SVP	Buy	105	$3.18	$333.90	165,054
7/6/2021	A.J. Kazimi	CEO	Buy	15	$3.14	$47.10	5,768,529
7/6/2021	Kenneth Krogulski	Director	Buy	85	$3.14	$266.90	172,085
7/6/2021	Martin E. Cearnal	SVP	Buy	105	$3.14	$329.70	165,054
7/2/2021	Martin E. Cearnal	SVP	Buy	105	$2.94	$308.70
7/1/2021	A.J. Kazimi	CEO	Buy	15	$2.91	$43.65	5,768,184
7/1/2021	Kenneth Krogulski	Director	Buy	85	$2.91	$247.35	172,085
6/30/2021	Martin E. Cearnal	SVP	Buy	105	$2.93	$307.65
6/28/2021	A.J. Kazimi	CEO	Buy	15	$3.16	$47.40	5,768,184
6/28/2021	Martin E. Cearnal	SVP	Buy	105	$3.16	$331.80	161,904
6/25/2021	A.J. Kazimi	CEO	Buy	15	$3.09	$46.35	5,768,184
6/25/2021	Martin E. Cearnal	SVP	Buy	105	$3.09	$324.45	161,904
6/23/2021	A.J. Kazimi	CEO	Buy	15	$3.07	$46.05	5,768,184
6/23/2021	Martin E. Cearnal	SVP	Buy	105	$3.07	$322.35	161,904
6/21/2021	A.J. Kazimi	CEO	Buy	15	$3.14	$47.10
6/21/2021	Martin E. Cearnal	SVP	Buy	105	$3.14	$329.70
6/18/2021	A. J. Kazimi	CEO	Buy	15	$2.99	$44.85	5,768,184
6/18/2021	Martin E. Cearnal	SVP	Buy	105	$2.99	$313.95
6/16/2021	A.J. Kazimi	CEO	Buy	15	$3.09	$46.35
6/16/2021	Martin E. Cearnal	SVP	Buy	105	$3.09	$324.45	161,904
6/14/2021	A.J. Kazimi	CEO	Buy	15	$3.09	$46.35	5,768,184
6/14/2021	Martin E. Cearnal	SVP	Buy	105	$3.11	$326.55	161,904
6/11/2021	A.J. Kazimi	CEO	Buy	15	$3.18	$47.70	5,768,184
6/11/2021	Martin E. Cearnal	SVP	Buy	105	$3.18	$333.90	161,904
6/9/2021	A.J. Kazimi	CEO	Buy	15	$3.14	$47.10
6/9/2021	Martin E. Cearnal	SVP	Buy	105	$3.14	$329.70	161,904
6/7/2021	A. J. Kazimi	CEO	Buy	15	$2.94	$44.10	5,768,184
6/7/2021	Martin E. Cearnal	SVP	Buy	105	$2.94	$308.70	161,904
6/3/2021	A. J. Kazimi	CEO	Buy	15	$2.81	$42.15	5,768,184
6/3/2021	Martin E. Cearnal	SVP	Buy	105	$2.81	$295.05	161,904
6/1/2021	A. J. Kazimi	CEO	Buy	15	$2.94	$44.10	5,768,184
6/1/2021	Martin E. Cearnal	SVP	Buy	105	$2.94	$308.70	161,904
5/28/2021	A.J. Kazimi	CEO	Buy	15	$2.93	$43.95
5/28/2021	Martin E. Cearnal	SVP	Buy	105	$2.93	$307.65
5/26/2021	A.J. Kazimi	CEO	Buy	15	$2.85	$42.75	5,767,734
5/26/2021	Martin E. Cearnal	SVP	Buy	105	$2.85	$299.25	161,904
5/24/2021	A. J. Kazimi	CEO	Buy	15	$3.05	$45.75	5,767,734
5/24/2021	Martin E. Cearnal	SVP	Buy	105	$3.02	$317.10	161,904
5/21/2021	A.J. Kazimi	CEO	Buy	15	$3.06	$45.90	5,767,734
5/21/2021	Martin E. Cearnal	SVP	Buy	105	$3.06	$321.30
5/19/2021	A.J. Kazimi	CEO	Buy	15	$2.83	$42.45
5/19/2021	Martin E. Cearnal	SVP	Buy	105	$2.83	$297.15
5/17/2021	A.J. Kazimi	CEO	Buy	15	$2.84	$42.60	5,767,734
5/17/2021	Martin E. Cearnal	SVP	Buy	5,805	$2.83	$16,428.15	148,814
5/14/2021	A.J. Kazimi	CEO	Buy	15	$2.81	$42.15
5/14/2021	Martin E. Cearnal	SVP	Buy	5,105	$2.77	$14,140.85	148,814
5/12/2021	A.J. Kazimi	CEO	Buy	15	$2.86	$42.90	5,767,734
5/12/2021	Martin E. Cearnal	SVP	Buy	105	$2.86	$300.30	148,814
5/10/2021	A.J. Kazimi	CEO	Buy	15	$2.71	$40.65
5/10/2021	Martin E. Cearnal	SVP	Buy	105	$2.71	$284.55	148,814
5/7/2021	A.J. Kazimi	CEO	Buy	15	$2.73	$40.95
5/7/2021	Martin E. Cearnal	SVP	Buy	105	$2.73	$286.65	148,814
5/5/2021	A. J. Kazimi	CEO	Buy	15	$2.73	$40.95	5,767,734
5/5/2021	Martin E. Cearnal	SVP	Buy	105	$2.73	$286.65	148,814
5/3/2021	A.J. Kazimi	CEO	Buy	15	$2.66	$39.90	5,767,734
5/3/2021	Martin E. Cearnal	SVP	Buy	105	$2.66	$279.30	148,814
4/30/2021	A.J. Kazimi	CEO	Buy	15	$2.78	$41.70	5,767,734
4/30/2021	Martin E. Cearnal	SVP	Buy	105	$2.78	$291.90	148,814
4/28/2021	A.J. Kazimi	CEO	Buy	15	$2.94	$44.10
4/28/2021	Martin E. Cearnal	SVP	Buy	80	$2.94	$235.20	148,814
4/26/2021	A.J. Kazimi	CEO	Buy	15	$2.97	$44.55	5,767,734
4/26/2021	Martin E. Cearnal	SVP	Buy	105	$2.97	$311.85	148,814
4/23/2021	A.J. Kazimi	CEO	Buy	15	$2.99	$44.85
4/23/2021	Martin E. Cearnal	SVP	Buy	105	$2.99	$313.95	148,814
4/21/2021	A. J. Kazimi	CEO	Buy	15	$2.97	$44.55	5,767,734
4/21/2021	Martin E. Cearnal	SVP	Buy	105	$2.97	$311.85	148,814
4/19/2021	A.J. Kazimi	CEO	Buy	15	$3.04	$45.60	5,767,734
4/19/2021	Martin E. Cearnal	SVP	Buy	105	$3.04	$319.20	148,814
4/16/2021	A.J. Kazimi	CEO	Buy	15	$3.03	$45.45	5,767,734
4/16/2021	Martin E. Cearnal	SVP	Buy	105	$3.03	$318.15	148,814

Lithium Discovery So BIG You Can't Miss it, Even From Space

From Financial Alphas | Ad

With the green energy transition well underway, lithium demand is rapidly outpacing projected supply. While companies frantically search for new sources of this critical metal, one small company is sitting on a massive claim in North America - So big in fact that it can clearly be seen from space!

Free Investor Report Reveals Ambitious Plan To Mee

SEC Filings (Institutional Ownership Changes) for Cumberland Pharmaceuticals (NASDAQ:CPIX)

16.70% of Cumberland Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Cumberland Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
10/24/2023	Bank of New York Mellon Corp	75,268	$0.14M	0.0%	N/A	0.524%
8/11/2023	Renaissance Technologies LLC	560,743	$0.82M	0.0%	-1.9%	3.881%
8/11/2023	BlackRock Inc.	113,691	$0.17M	0.0%	-13.8%	0.787%
8/9/2023	Dimensional Fund Advisors LP	507,290	$0.75M	0.0%	-16.7%	3.511%
7/27/2023	B. Riley Wealth Advisors Inc.	90,298	$0.13M	0.0%	N/A	0.625%
5/12/2023	Renaissance Technologies LLC	571,663	$1.12M	0.0%	-1.8%	3.970%
5/12/2023	BlackRock Inc.	131,938	$0.26M	0.0%	-6.2%	0.916%
5/12/2023	Dimensional Fund Advisors LP	609,033	$1.19M	0.0%	-2.4%	4.229%
2/15/2023	Millennium Management LLC	20,376	$46K	0.0%	N/A	0.139%
2/14/2023	Two Sigma Investments LP	38,430	$86K	0.0%	-15.0%	0.262%
2/13/2023	Renaissance Technologies LLC	581,963	$1.31M	0.0%	-2.5%	3.970%
2/10/2023	True Capital Management	12,025	$27K	0.0%	N/A	0.082%
11/15/2022	Two Sigma Advisers LP	24,700	$60K	0.0%	-28.6%	0.168%
11/15/2022	Two Sigma Investments LP	45,215	$0.11M	0.0%	-12.2%	0.308%
11/14/2022	Renaissance Technologies LLC	596,863	$1.44M	0.0%	-4.1%	4.071%
8/13/2022	Renaissance Technologies LLC	622,228	$1.29M	0.0%	-3.5%	4.214%
5/24/2022	M Holdings Securities Inc.	10,750	$30K	0.0%	N/A	0.073%
5/16/2022	State Street Corp	42,045	$0.12M	0.0%	-36.1%	0.283%
5/13/2022	Renaissance Technologies LLC	644,763	$1.82M	0.0%	+6.3%	4.345%
5/13/2022	Vanguard Group Inc.	377,984	$1.07M	0.0%	-3.4%	2.547%
5/13/2022	Dimensional Fund Advisors LP	633,904	$1.79M	0.0%	-2.9%	4.272%
5/12/2022	Acadian Asset Management LLC	188,243	$0.53M	0.0%	+27.8%	1.268%
2/10/2022	Acadian Asset Management LLC	147,294	$0.68M	0.0%	-9.2%	0.995%
2/9/2022	Dimensional Fund Advisors LP	652,561	$3.05M	0.0%	-6.3%	4.406%
11/15/2021	Berkshire Asset Management LLC PA	176,185	$0.47M	0.0%	+3.1%	1.184%
11/15/2021	Dimensional Fund Advisors LP	696,654	$1.88M	0.0%	-7.8%	4.682%
11/12/2021	Renaissance Technologies LLC	664,564	$1.78M	0.0%	-5.3%	4.466%
11/9/2021	BlackRock Inc.	333,051	$0.89M	0.0%	-15.9%	2.238%
8/17/2021	Berkshire Asset Management LLC PA	170,830	$0.49M	0.0%	+3.2%	1.135%
8/13/2021	Renaissance Technologies LLC	701,463	$2M	0.0%	-6.9%	4.661%
8/13/2021	California Public Employees Retirement System	10,205	$29K	0.0%	-79.3%	0.068%
8/13/2021	Ariel Investments LLC	12,033	$34K	0.0%	-94.3%	0.080%
8/12/2021	Dimensional Fund Advisors LP	755,500	$2.15M	0.0%	+2.4%	5.020%
5/21/2021	Citadel Advisors LLC	17,005	$52K	0.0%	N/A	0.113%
5/18/2021	Citadel Advisors LLC	17,005	$52K	0.0%	N/A	0.114%
5/14/2021	Arrowstreet Capital Limited Partnership	10,700	$32K	0.0%	N/A	0.072%
5/14/2021	Dimensional Fund Advisors LP	737,881	$2.24M	0.0%	-5.6%	4.945%
5/13/2021	Renaissance Technologies LLC	753,053	$2.28M	0.0%	+11.5%	5.047%
5/12/2021	M Holdings Securities Inc.	10,750	$33K	0.0%	N/A	0.072%
5/11/2021	Acadian Asset Management LLC	175,015	$0.53M	0.0%	+66.7%	1.173%
3/8/2021	Dimensional Fund Advisors LP	781,891	$2.30M	0.0%	-2.1%	5.207%
2/25/2021	Dimensional Fund Advisors LP	781,891	$2.30M	0.0%	-2.1%	5.207%
2/12/2021	Stonepine Capital Management LLC	188,703	$0.56M	0.4%	-68.0%	1.257%
2/12/2021	Ariel Investments LLC	821,096	$2.42M	0.0%	+4.9%	5.468%
2/10/2021	Renaissance Technologies LLC	675,159	$1.99M	0.0%	+12.6%	4.496%
2/10/2021	Sterling Financial Planning Inc.	22,031	$65K	0.1%	N/A	0.147%
11/13/2020	Stonepine Capital Management LLC	589,497	$1.89M	2.0%	-12.9%	3.894%
11/6/2020	BlackRock Inc.	364,974	$1.17M	0.0%	+2.1%	2.411%
7/16/2020	Wedbush Securities Inc.	13,041	$43K	0.0%	N/A	0.086%
5/15/2020	Morgan Stanley	12,168	$44K	0.0%	-20.5%	0.080%
5/14/2020	Stonepine Capital Management LLC	907,735	$3.30M	3.5%	+1.3%	5.979%
5/11/2020	Acadian Asset Management LLC	92,643	$0.34M	0.0%	-5.7%	0.610%
5/1/2020	BlackRock Inc.	327,615	$1.19M	0.0%	-1.2%	2.158%
2/14/2020	Ariel Investments LLC	1,010,220	$5.20M	0.1%	+5.4%	6.653%
2/6/2020	Acadian Asset Management LLC	98,192	$0.51M	0.0%	-3.0%	0.647%
10/18/2019	Bailard Inc.	11,816	$70K	0.0%	-18.6%	0.077%
10/15/2019	Financial Gravity Wealth Inc.	6,000	$36K	0.0%	N/A	0.039%
10/10/2019	Dalton Greiner Hartman Maher & Co.	89,100	$0.53M	0.0%	N/A	0.580%
8/13/2019	Stonepine Capital Management LLC	871,762	$5.55M	3.8%	-27.5%	5.611%
8/13/2019	BlackRock Inc.	332,543	$2.12M	0.0%	+17.2%	2.140%
8/12/2019	Renaissance Technologies LLC	441,577	$2.81M	0.0%	+13.0%	2.842%
8/8/2019	Acadian Asset Management LLC	104,498	$0.67M	0.0%	+6.9%	0.672%
6/30/2019	Bailard Inc.	14,516	$92K	0.0%	N/A	0.093%
4/1/2019	Deutsche Bank AG	12,127	$72K	0.0%	-34.3%	0.078%
2/13/2019	Stonepine Capital Management LLC	1,313,429	$7.92M	7.0%	+7.8%	8.458%
2/13/2019	Dimensional Fund Advisors LP	880,248	$5.55M	0.0%	+0.2%	5.669%
2/8/2019	BlackRock Inc.	306,901	$1.85M	0.0%	-3.0%	1.976%
11/13/2018	Stonepine Capital Management LLC	1,218,401	$6.96M	4.1%	+1.3%	7.845%
11/9/2018	BlackRock Inc.	316,232	$1.81M	0.0%	-4.3%	2.031%
10/30/2018	Acadian Asset Management LLC	97,733	$0.56M	0.0%	-9.9%	0.628%
8/14/2018	Stonepine Capital Management LLC	1,203,339	$7.38M	4.5%	-9.0%	7.660%
8/13/2018	Renaissance Technologies LLC	377,209	$2.31M	0.0%	+6.7%	2.401%
8/10/2018	Ariel Investments LLC	1,305,052	$8M	0.1%	+28.7%	8.307%
8/10/2018	Dimensional Fund Advisors LP	872,674	$5.35M	0.0%	-1.2%	5.555%
5/11/2018	JW Asset Management LLC	178,942	$1.20M	1.2%	-32.2%	1.143%
5/9/2018	BlackRock Inc.	332,482	$2.22M	0.0%	-11.9%	2.124%
5/4/2018	Prudential Financial Inc.	20,600	$0.14M	0.0%	N/A	0.132%
2/14/2018	Ariel Investments LLC	910,076	$6.70M	0.1%	+2.6%	5.778%
2/13/2018	Renaissance Technologies LLC	330,300	$2.43M	0.0%	+4.5%	2.097%
2/13/2018	Stonepine Capital Management LLC	1,306,911	$9.62M	5.8%	+2.7%	8.298%
2/9/2018	BlackRock Inc.	377,217	$2.78M	0.0%	-4.2%	2.395%
11/13/2017	Stonepine Capital Management LLC	1,272,191	$8.98M	5.3%	+14.7%	8.077%
11/6/2017	New York State Common Retirement Fund	250,230	$1.77M	0.0%	-7.1%	1.574%
10/30/2017	Essex Investment Management Co. LLC	34,494	$0.24M	0.0%	+116.1%	0.217%
8/14/2017	Stonepine Capital Management LLC	1,109,167	$7.76M	4.2%	+49.9%	6.918%
8/11/2017	Dimensional Fund Advisors LP	866,283	$6.13M	0.0%	+0.3%	5.403%
8/11/2017	California Public Employees Retirement System	53,800	$0.38M	0.0%	No Change	0.336%
8/11/2017	Vanguard Group Inc.	298,635	$2.11M	0.0%	+0.4%	1.863%
8/11/2017	New York State Common Retirement Fund	269,377	$1.90M	0.0%	-8.5%	1.680%
8/10/2017	Ameriprise Financial Inc.	23,892	$0.17M	0.0%	+0.3%	0.149%
8/10/2017	Bard Associates Inc.	88,515	$0.62M	0.3%	-0.1%	0.552%
8/4/2017	JW Asset Management LLC	263,881	$1.85M	1.2%	No Change	1.646%
8/3/2017	Bank of New York Mellon Corp	20,338	$0.14M	0.0%	No Change	0.127%
7/28/2017	Essex Investment Management Co. LLC	15,959	$0.11M	0.0%	+45.8%	0.100%
7/27/2017	Spark Investment Management LLC	20,300	$0.14M	0.0%	-10.2%	0.127%
7/27/2017	Eagle Global Advisors LLC	52,767	$0.37M	0.0%	No Change	0.329%
7/25/2017	Acadian Asset Management LLC	130,073	$0.91M	0.0%	-0.3%	0.811%
5/12/2017	Stonepine Capital Management LLC	739,917	$5.14M	2.9%	+19.4%	4.621%
5/12/2017	United Capital Financial Advisers LLC	36,626	$0.25M	0.0%	No Change	0.229%
5/12/2017	Bard Associates Inc.	88,565	$0.62M	0.3%	-4.3%	0.553%

Data available starting January 2016

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; and Vibativ, an injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections. It also develops RediTrex injection for the treatment of active rheumatoid, juvenile idiopathic, and severe psoriatic arthritis, as well as disabling psoriasis. In addition, the company is developing ifetroban, a product candidate that is in phase II clinical trial for the treatment of aspirin-exacerbated respiratory disease, systemic sclerosis, and duchenne muscular dystrophy; and has completed phase II clinical trial for the treatment of hepatorenal syndrome and portal hypertension. Further, it develops a clinical program for the use of ifetroban to treat progressive fibrosing interstitial lung diseases; and a product candidate for cholesterol reducing agent to use in the hospital setting. The company was incorporated in 1999 and is headquartered in Nashville, Tennessee.

Today's Range

Now: $1.70

$1.62

$1.71

50 Day Range

MA: $1.86

$1.60

$2.14

52 Week Range

Now: $1.70

$1.43

$2.91

Volume

3,227 shs

Average Volume

20,075 shs

Market Capitalization

$24.24 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.13

Who are the company insiders with the largest holdings of Cumberland Pharmaceuticals?: Cumberland Pharmaceuticals' top insider investors include:
Kenneth Krogulski (Director)
James Jones (Director)
Caroline Young (Director)
Learn More about top insider investors at Cumberland Pharmaceuticals.
Who are the major institutional investors of Cumberland Pharmaceuticals?: Cumberland Pharmaceuticals' top institutional shareholders include:
Bank of New York Mellon Corp — 0.52%
Concourse Financial Group Securities Inc. — 0.00%
Learn More about top institutional investors of Cumberland Pharmaceuticals stock.
Which institutional investors are buying Cumberland Pharmaceuticals stock?: Within the last quarter, CPIX stock was acquired by institutional investors including:
Bank of New York Mellon Corp
In the last year, these company insiders have bought Cumberland Pharmaceuticals stock:
Kenneth Krogulski (Director)
James Jones (Director)
Caroline Young (Director)
Learn More investors buying Cumberland Pharmaceuticals stock.